3-Methylamino-1-(2-thienyl)-1-propanol CAS NO.116539-55-0

this intermediate is used for duloxetine intermediate, we own the dmf(26862), this intermediate was produced on ton scale, with high purity and high ee.

chiral quest was founded in 2000, we provide chemical development and contract manufacturing services to meet demand at all stages of development (kilo-lab, pilot-plant and commercial scale manufacture).

chiral quest has a manufacturing site in jiangxi province, headquarters and r&d centre located in suzhou industrial park; and three overseas offices located in usa, europe and india. we have expertise in asymmetric hydrogenation, multi-step synthesis, coupling reactions and cryogenic reactions. with 13 granted u.s. patents for asymmetric hydrogenation catalysts and 6 process patents for innovative routes to generic api intermediates.

chiral quest’s mission is to create value for the global healthcare industry by using economic and environmentally friendly methods to manufacture single enantiomer pharmaceutical intermediates.